OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001101026

Zivo Bioscience, Inc. (ZIVO)

Zivo Bioscience, Inc. (CIK 0001101026, ticker ZIVO, EIN 87-0699977) reported revenue of $157,220 for FY2024 (2024-01-01 to 2024-12-31) and net income of -$13.38 million (-$13,384,836) for FY2024 (2024-01-01 to 2024-12-31), as filed in its 10-K filed 2025-03-18 (accession 0001654954-25-002948).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001101026
TickersZIVO (OTC)
EIN87-0699977
SIC industry code2836 Biological Products, (No Diagnostic Substances)
State or country of incorporationNV
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_7zbs9g4aqfdnbfta2fa6e60092
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$157,220FY20242024-01-01 to 2024-12-3110-K2025-03-180001654954-25-002948Revenues
Net income-$13,384,836FY20242024-01-01 to 2024-12-3110-K2025-03-180001654954-25-002948NetIncomeLoss
Total assets$1,643,122FY2024as of 2024-12-3110-K2025-03-180001654954-25-002948Assets
Total liabilities$2,158,019FY2024as of 2024-12-3110-K2025-03-180001654954-25-002948Liabilities
Stockholders' equity-$514,897FY2024as of 2024-12-3110-K2025-03-180001654954-25-002948StockholdersEquity
Operating cash flow-$4,313,510FY20242024-01-01 to 2024-12-3110-K2025-03-180001654954-25-002948NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$4.23 per shareFY20242024-01-01 to 2024-12-3110-K2025-03-180001654954-25-002948EarningsPerShareDiluted
Shares outstanding3,759,213 sharesFY2024as of 2025-03-1210-K2025-03-180001654954-25-002948EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2015-2024, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20242024-01-01 to 2024-12-31$157,22010-K2025-03-180001654954-25-002948
RevenueFY20232023-01-01 to 2023-12-31$27,65010-K2025-03-180001654954-25-002948
RevenueFY20222022-01-01 to 2022-12-31$010-K2024-03-150001654954-24-003228
RevenueFY20212021-01-01 to 2021-12-31$010-K2023-03-140001654954-23-002845
RevenueFY20202020-01-01 to 2020-12-31$20,00010-K2022-04-220001654954-22-005298
RevenueFY20192019-01-01 to 2019-12-31$010-K2021-02-250001078782-21-000172
RevenueFY20182018-01-01 to 2018-12-31$010-K2020-03-260001078782-20-000199
RevenueFY20162016-01-01 to 2016-12-31$010-K2017-03-310001078782-17-000387
RevenueFY20152015-01-02 to 2015-12-31$010-K2017-03-310001078782-17-000387
Net incomeFY20242024-01-01 to 2024-12-31-$13,384,83610-K2025-03-180001654954-25-002948
Net incomeFY20232023-01-01 to 2023-12-31-$7,777,18410-K2025-03-180001654954-25-002948
Net incomeFY20222022-01-01 to 2022-12-31-$8,745,29310-K2024-03-150001654954-24-003228
Net incomeFY20212021-01-01 to 2021-12-31-$8,755,88110-K2023-03-140001654954-23-002845
Net incomeFY20202020-01-01 to 2020-12-31-$9,105,72910-K2022-04-220001654954-22-005298
Net incomeFY20192019-01-01 to 2019-12-31-$11,510,16610-K2021-02-250001078782-21-000172
Net incomeFY20182018-01-01 to 2018-12-31-$14,635,36710-K2020-03-260001078782-20-000199
Net incomeFY20162016-01-01 to 2016-12-31-$6,059,62710-K2017-03-310001078782-17-000387
Net incomeFY20152015-01-02 to 2015-12-31-$5,789,13110-K2017-03-310001078782-17-000387
  • Net income for FY2021 was restated: first reported as -$9,163,366 (accession 0001654954-22-005298, filed 2022-04-22).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2025-11-142025-09-300001654954-25-013095zivo_10q.htm
10-Q2025-08-142025-06-300001654954-25-009650zivo_10q.htm
10-Q2025-05-152025-03-310001654954-25-005748zivo_10q.htm
10-K2025-03-182024-12-310001654954-25-002948zivo_10k.htm
10-Q2024-11-142024-09-300001654954-24-014463zivo_10q.htm
10-Q2024-08-142024-06-300001654954-24-010644zivo_10q.htm
10-Q2024-05-132024-03-310001654954-24-006082zivo_10q.htm
10-K2024-03-152023-12-310001654954-24-003228zivo_10k.htm
10-Q2023-11-132023-09-300001654954-23-014165zivo_10q.htm
10-Q2023-08-142023-06-300001654954-23-010769zivo_10q.htm
10-Q2023-05-102023-03-310001654954-23-006097zivo_10q.htm
10-K2023-03-142022-12-310001654954-23-002845zivo_10k.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001101026published by the sourcedata.sec.gov/submissions/CIK0001101026.json2026-10-21
Employer Identification Number (EIN) · US-EIN87-0699977published by the sourcedata.sec.gov/submissions/CIK0001101026.json2026-10-21

Former names

NameFromTo
HEALTH ENHANCEMENT PRODUCTS INC2004-02-062014-10-16
WESTERN GLORY HOLE INC2000-06-192004-01-26

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001101026.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001101026.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001101026" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001101026/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001101026/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1101026"}

On SEC EDGAR

About this data